Collins Cooper C.'s Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Aug 19, 2021
- Accession no.
- 0001387131-21-008733
- Filed
- Aug 19, 2021
- Trade date
- Aug 17-18, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $725.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Collins Cooper C.CIK 0001485508 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Common Stock | PPurchaseAcquired | +100,000 | $0.77 | +$77,000 | 336,864 | Direct | |
| Aug 18, 2021 | Common Stock | PPurchaseAcquired | +900,000 | $0.72 | +$648,000 | 1,236,864 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.